Exhibit 1




In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.0001 par value per share, of Corbus Pharmaceuticals Holdings, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof, the undersigned hereby execute this Agreement.


Dated: February 5, 2024


Paradigm BioCapital Advisors LP  
Paradigm BioCapital Advisors GP LLC  
Paradigm BioCapital International Fund Ltd.  
By:   /s/ David K. Kim  
Name:  David K. Kim  
Title:  Authorized Signatory  
/s/ Senai Asefaw, M.D.  
Senai Asefaw, M.D.